Vaccine candidate against Chikungunya fever proves successful
A prophylactic vaccine candidate against Chikungunya fever, developed by the Austrian biotech company Themis Bioscience GmbH induces a significant neutralizing immune response and was also confirmed as safe. These are the ...
Jun 12, 2014
0
0